Holen Sie sich die Stockscreener-App
55.23
0.00%
0.00
Handel nachbörslich:
55.23
Haemonetics Corp Aktie (HAE) Neueste Nachrichten
Quantitative breakdown of Haemonetics Corporation recent moveEarnings Risk Summary & Real-Time Price Movement Reports - Newser
Can Haemonetics Corporation hit a new high this monthEarnings Risk Report & Detailed Earnings Play Strategies - Newser
Full technical analysis of Haemonetics Corporation stockEarnings Miss & Fast Gain Stock Trading Tips - Newser
Can a trend reversal in Haemonetics Corporation lead to recoveryEarnings Growth Report & Pattern Based Trade Signal System - Newser
Can machine learning forecast Haemonetics Corporation recoveryAnalyst Upgrade & Stock Market Timing Techniques - Newser
Technical Charts Suggest Momentum Shift in Haemonetics CorporationWeekly Risk Summary & Low Risk High Reward Ideas - thegnnews.com
How to escape a deep drawdown in Haemonetics CorporationMarket Performance Report & Verified Short-Term Plans - Newser
Vanguard Group Inc. Has $324.08 Million Stake in Haemonetics Corporation $HAE - Defense World
Should you hold or exit Haemonetics Corporation nowQuarterly Market Review & Risk Managed Investment Strategies - Newser
What makes Haemonetics Corporation stock attractive to long term investorsFed Meeting & Daily Oversold Bounce Ideas - Newser
Analyzing net buyer seller activity in Haemonetics CorporationJuly 2025 WrapUp & Verified Chart Pattern Signals - Newser
PNC Financial Services Group Inc. Has $294,000 Stock Holdings in Haemonetics Corporation (NYSE:HAE) - Defense World
Will Haemonetics Corporation see short term momentum2025 Major Catalysts & Reliable Entry Point Trade Alerts - Newser
Is Haemonetics Corporation stock entering bullish territory2025 Technical Overview & Stepwise Swing Trade Plans - Newser
Is Haemonetics Corporation meeting your algorithmic filter criteriaJuly 2025 Weekly Recap & Technical Buy Zone Confirmations - Newser
Haemonetics Corporation stock outlook for YEAR2025 Retail Activity & High Yield Stock Recommendations - Newser
Patient Blood Management Market Growth Analysis Report 2025-2033 | AI-Driven Analytics Revolutionize Blood Management Strategies, Blockchain Enhances Supply Transparency and Safety - GlobeNewswire Inc.
Mizuho lowers Haemonetics stock price target to $70 on VASCADE MVP slowdown - Investing.com Nigeria
The Top 5 Analyst Questions From Haemonetics’s Q2 Earnings Call - Yahoo Finance
Advanced analytics toolkit walkthrough for Haemonetics CorporationQuarterly Portfolio Review & High Conviction Trade Alerts - Newser
Haemonetics Corporation Shows Support at Fibonacci Level2025 Buyback Activity & Fast Entry High Yield Tips - metal.it
Haemonetics (NYSE:HAE) Rating Lowered to Outperform at Raymond James Financial - Defense World
Haemonetics Corporation (NYSE:HAE) Q1 2026 Earnings Call Transcript - Insider Monkey
I’m Recommending Haemonetics Again, But With Caveats (Ratings Upgrade) (NYSE:HAE) - Seeking Alpha
Haemonetics Corporation shares fall 2.69% intraday after Raymond James downgrades to Outperform. - AInvest
Understanding Haemonetics (HAE) Reliance on International Revenue - Yahoo Finance
Haemonetics stock rating downgraded by Raymond James on vascular closure slowdown - Investing.com
Haemonetics’ (HAE) “Neutral” Rating Reiterated at JPMorgan Chase & Co. - Defense World
Mizuho Issues Pessimistic Forecast for Haemonetics (NYSE:HAE) Stock Price - Defense World
Haemonetics (NYSE:HAE) Price Target Cut to $68.00 by Analysts at Needham & Company LLC - Defense World
Barrington Research Lowers Haemonetics (NYSE:HAE) Price Target to $86.00 - Defense World
Haemonetics’ (HAE) Buy Rating Reiterated at Needham & Company LLC - Defense World
A Quick Look at Today's Ratings for Haemonetics(HAE.US), With a Forecast Between $62 to $86 - 富途牛牛
Detecting price anomalies in Haemonetics Corporation with AIFree Trade Ready Stock Watch for Short Term - Newser
What makes Haemonetics Corporation stock price move sharplyAI Swing Strategy Signal Forecasting System - Newser
Haemonetics Reports Q1 Fiscal 2026 Earnings - The Globe and Mail
JP Morgan Downgrades Haemonetics (HAE) - MSN
Haemonetics Corporation stock trendline breakdownFree Breakout Confirmation With Entry Tracker - Newser
Haemonetics Corp Reports Strong Organic Growth Despite Portfolio Transitions - AInvest
These Analysts Slash Their Forecasts On Haemonetics After Q1 Results - Benzinga
Haemonetics (HAE): Mizuho Lowers Price Target to $70.00 While Ma - GuruFocus
This Trade Desk Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Benzinga
Technical signs of recovery in Haemonetics CorporationSummary of Consistent Growth Stock Picks - Newser
A Glimpse Into The Expert Outlook On Haemonetics Through 6 Analysts - 富途牛牛
Haemonetics: Fiscal Q1 Earnings Snapshot - Connecticut Post
Haemonetics stock rating cut by JPMorgan on mixed results - Investing.com
Haemonetics (NYSE:HAE) Shares Down 22.1% Following Analyst Downgrade - Defense World
Haemonetics' Q1 2026 Earnings Call: Key Contradictions in Plasma Growth, Margins, and Competitive Strategy - AInvest
Decoding Haemonetics Corp (HAE): A Strategic SWOT Insight - GuruFocus
Haemonetics Corp (HAE) Analysts Lower Price Target to $68, Maintain "Buy" Rating - AInvest
Haemonetics (NYSE:HAE) Surprises With Strong Q2 But Stock Drops 24% - Yahoo Finance
Analyst Needham Lowers Price Target for Haemonetics (HAE) to $68 - GuruFocus
0.86%
0.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):